2 news items
WuXi Biologics Reports Solid 2023 Annual Results
BNTX
FOLD
GSK
26 Mar 24
certainty and stability through our strategic initiatives. Looking ahead to 2024, we are committed to serving and contributing to the global healthcare
Earnings Scheduled For February 28, 2024
NOVT
NRG
NSA
28 Feb 24
(NASDAQ:CRNX) is estimated to report quarterly loss at $0.86 per share on revenue of $260 thousand.
• Definitive Healthcare
- Prev
- 1
- Next